NSAIDs in Dialysis Patients: Recommendations

Introduction to NSAID Use in Dialysis

The American College of Cardiology and other guideline societies recommend that NSAIDs should be avoided in patients already on dialysis, but if absolutely necessary for pain management, they can be used with extreme caution for the shortest possible duration, as the primary concern shifts from preventing further renal decline to managing cardiovascular complications, fluid retention, and electrolyte disturbances 1

NSAIDs cause sodium and water retention, which can worsen volume overload, hypertension, and heart failure—critical issues in dialysis patients who already struggle with fluid management between dialysis sessions, with the European Society of Cardiology giving NSAIDs a Class III (harm) recommendation in heart failure patients 3, 1
The European Society of Cardiology recommends that NSAIDs be used with caution in patients with heart failure, as they cause sodium and water retention, worsening renal function and worsening heart failure 1

Hyperkalemia is a major concern, as dialysis patients already have impaired potassium excretion and NSAIDs further reduce potassium elimination, particularly if patients are taking ACE inhibitors, ARBs, or potassium-sparing diuretics 3

NSAIDs increase cardiovascular morbidity and mortality in high-risk populations, and dialysis patients have extremely high baseline cardiovascular risk 1

Monitor interdialytic weight gain closely, as NSAIDs will increase fluid retention and may necessitate ultrafiltration adjustments, and check serum potassium before and during NSAID therapy, especially if patient is on RAAS blockers or potassium-sparing diuretics 1, 3
Monitor blood pressure more frequently, as NSAIDs will likely increase it, and assess for signs of volume overload (peripheral edema, pulmonary congestion, increased interdialytic weight gain) 1, 3

The combination of NSAIDs with ACE inhibitors, ARBs, and diuretics creates compounded risk for hyperkalemia and cardiovascular complications, and avoid concurrent use with anticoagulants (warfarin) due to 5-6 fold increased risk of gastrointestinal bleeding 1, 4

If NSAIDs must be used, consider proton pump inhibitors (PPIs) or misoprostol for gastroprotection, as dialysis patients have increased GI bleeding risk 4